Detalhe da pesquisa
1.
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma.
N Engl J Med
; 389(7): 589-601, 2023 Aug 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37272516
2.
The 2022 European postgraduate (residency) programme in neurology in a historical and international perspective.
Eur J Neurol
; 31(3): e15909, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37294693
3.
Antiangiogenic Therapy for Malignant Brain Tumors: Does It Still Matter?
Curr Oncol Rep
; 25(7): 777-785, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37071295
4.
Neurotoxicity from Old and New Radiation Treatments for Brain Tumors.
Int J Mol Sci
; 24(13)2023 Jun 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37445846
5.
Observational real-life study on regorafenib in recurrent glioblastoma: does dose reduction reduce toxicity while maintaining the efficacy?
J Neurooncol
; 160(2): 389-402, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36309895
6.
COVID-19 vaccination hesitancy among people with chronic neurological disorders: A position paper.
Eur J Neurol
; 29(8): 2163-2172, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35460319
7.
Ependymoma: Evaluation and Management Updates.
Curr Oncol Rep
; 24(8): 985-993, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35384591
8.
Evaluation of the 2020 European Academy of Neurology virtual congress: transition from a face-to-face to a virtual meeting.
Eur J Neurol
; 28(8): 2523-2532, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33369806
9.
A plea for equitable global access to COVID-19 diagnostics, vaccination and therapy: The NeuroCOVID-19 Task Force of the European Academy of Neurology.
Eur J Neurol
; 28(11): 3849-3855, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33460486
10.
Systemic Therapy for Lung Cancer Brain Metastases.
Curr Treat Options Oncol
; 22(12): 110, 2021 10 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34693454
11.
Blood-Brain Barrier in Brain Tumors: Biology and Clinical Relevance.
Int J Mol Sci
; 22(23)2021 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34884457
12.
Targeted Therapies in Rare Brain Tumours.
Int J Mol Sci
; 22(15)2021 Jul 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34360713
13.
Is chemotherapy alone an option as initial treatment for low-grade oligodendrogliomas?
Curr Opin Neurol
; 33(6): 707-715, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33027142
14.
Management of Brain and Leptomeningeal Metastases from Breast Cancer.
Int J Mol Sci
; 21(22)2020 Nov 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33198331
15.
NTRK Fusions in Central Nervous System Tumors: A Rare, but Worthy Target.
Int J Mol Sci
; 21(3)2020 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31979374
16.
Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial.
Lancet Oncol
; 20(1): 110-119, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30522967
17.
Strategies to prevent brain metastasis.
Curr Opin Oncol
; 31(6): 493-500, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31414987
18.
Use of Antidepressants and Risk of Incident Stroke: A Systematic Review and Meta-Analysis.
Neuroepidemiology
; 53(3-4): 142-151, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31216542
19.
Efficacy of initial temozolomide for high-risk low grade gliomas in a phase II AINO (Italian Association for Neuro-Oncology) study: a post-hoc analysis within molecular subgroups of WHO 2016.
J Neurooncol
; 145(1): 115-123, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31556015
20.
Correction to: Efficacy of initial temozolomide for highrisk low grade gliomas in a phase II AINO (Italian Association for NeuroOncology) study: a posthoc analysis within molecular subgroups of WHO 2016.
J Neurooncol
; 145(3): 593, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31691059